either before, during, or after the inflammatory response ap- pears. Usually this pain subsides, but if it persists or recurs after the rash subsides, it is referred to as PHN. PHN is considered to be a chronic neuropathic pain condi- tion involving aberrant somatosensory processing in the pe- ripheral and central nervous systems. Because improper peripheral nerve signaling appears in a large portion of PHN patients, treatment strategies affecting peripheral nerves have been developed, including topical low-concentration (<0.1% w/w) capsaicin cream and lidocaine patches. Qutenza, a nonsystemic highly pure (8%) capsaicin dermal patch was developed to avoid repeated daily capsaicin appli- cations. Qutenza is approved by the FDA for the management of neuropathic pain associated with PHN with an effective therapy for up to 3 months after a single application. This presentation describes the PHN disease process, the mechanism of action of Qutenza, and the results of two piv- otal trials using Qutenza for the treatment of PHN. We also dis- cuss the treatment procedure used to apply the Qutenza dermal patch as well as the implication for nurses. Journey to Excellence: A Clinical Guideline for Analgesia after Pediatric Nuss Procedure for Pectus Excavatum Mary Lyons, MSN, RN-BC, DNC, APN Central DuPage Hospital, Winfield, IL Susan Buck, MS, CPNP, APN To prepare for a new patient population at our community hos- pital, staff attended a conference to learn about the minimally invasive Nuss procedure for correction of pectus excavatum and how to best provide postoperative care as established at Children’s Hospital of the King’s Daughters, Norfolk, VA. Initial preparation included developing a pain management plan of care to achieve excellent analgesia to maximize mobility and minimize complications. After a review of the literature and in- quiries to the ASPMN/APS listserve, only two published studies were identified that addressed postoperative analgesia in this population. With no obvious ‘‘best practice’’ to follow, the Pe- diatric surgical and pain management Advanced Practice Nurses began collaborating with the pediatric anesthesiologists to develop a plan for epidural management with transition of care to pediatric hospitalists after epidural analgesia. A data- base tracking the analgesic course was kept to evaluate each patient’s progress owing to extended periods of time between cases. It became obvious that in addition to using established order sets, a written guideline would provide improved com- munication for the multidisciplinary team across the patient’s continuum of care. We share with the audience our journey while caring for 15 patients over the past 2 years with case ex- amples, successes, and lessons learned in addition to evalua- tion of the use of a mulitidisciplinary clinical guideline. Choice-Based Conjoint Analysis to Elicit Preferences for Cancer Pain Treatment between African Americans and European Americans Salimah H. Meghani, PhD, MBE, CRNP, RN University of Pennsylvania, Philadelphia, PA PURPOSE Patient-level factors remain underinvestigated in the accumu- lating literature on racial/ethnic disparities in pain treatment. This study used choice-based conjoint analysis (CBC), a pref- erence-elicitation technique grounded in random utility the- ory, to understand if and how preferences for analgesic treatment for cancer pain vary between African Americans (AA) and European Americans (EA). METHODS Self-identified AA and EA (n ¼ 76; 35 AA, 41 EA), >18 years old, diagnosed with solid tumors, with cancer-related pain in the week before the survey, were recruited from outpatient medical oncology clinic in the mid-Atlantic region. Analgesic preference was elicited using computer-based CBC survey, and pain treatment characteristics were assessed using the Brief Pain Inventory (BPI), Medication Side Effect Checklist (MSEC), and Barriers-Questionnaire (BQ-II). Mann-Whitney U test for continuous and Fisher exact test for categoric vari- ables were used to analyze data. The study was approved by the University of Pennsylvania Institutional Review Board. RESULTS AA and EA did not differ in age (p ¼ .552), gender (p ¼ .095), education (p ¼ .164), insurance (p ¼ .461), or health literacy (p ¼ .911). However, AA reported higher pain (BPI ‘‘pain- average’’ 5.2 vs. 4.5; p ¼ .040) and lower relief with analgesics (BPI ‘‘pain-least’’ 3.9 vs. 2.8; p ¼ .015). Also, there was a trend for AA to report more side effects, (MSEC 24.7 vs. 19.2; p ¼ .076) as well as barriers to using analgesics (BQ-II 80.0 vs. 71.0; p ¼ .067). Based on the calculated utilities, the groups did not differ in their concern for various analgesic attributes, including type of analgesic (p ¼ .149), percentage relief with -analgesics (p ¼ .954), side effect type (p ¼ .946), severity (p ¼ .085), or out-of-pocket cost (p ¼ .950). However, for AA, being ‘‘strong’’ and not talking about pain was more im- portant in making pain treatment decisions (mean rank, 44.3 vs. 33.5; p ¼ .033). AA were also likely to express more barriers in the communication subscale of the BQ-II (13.6 vs. 10.9; p ¼ .046). This is despite the fact that AA and EA did not differ in education or health literacy in this sample. CONCLUSIONS On average, AA and EA may use different heuristics in making decisions about cancer pain treatment, which requires further investigation. A Report of the Strategic Planning Summit for Pain and Palliative Care Pharmacy Mary Lynn McPherson, PharmD, BCPS, CPE University of Maryland School of Pharmacy, Baltimore, MD C. M. Herndon; D. Craig; L. Krae; S. Nesbit; R. Finley; S. Strassels INTRODUCTION The participation of pharmacists in the care of persons in pain or in need of palliative care has become essential as the complexity of medication regimens as well as our aging pop- ulation grows. The Strategic Planning Summit for the Pain Management Nursing, Vol 12, No 2 (June), 2011: pp e1-e11 e5 Meeting Abstracts